Logo image of CLBT

CELLEBRITE DI LTD (CLBT) Stock Fundamental Analysis

NASDAQ:CLBT - Nasdaq - IL0011794802 - Common Stock - Currency: USD

15.25  -0.2 (-1.29%)

After market: 15.43 +0.18 (+1.18%)

Fundamental Rating

5

Taking everything into account, CLBT scores 5 out of 10 in our fundamental rating. CLBT was compared to 282 industry peers in the Software industry. While CLBT has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, CLBT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CLBT was profitable.
CLBT had a positive operating cash flow in the past year.
In multiple years CLBT reported negative net income over the last 5 years.
Each year in the past 5 years CLBT had a positive operating cash flow.
CLBT Yearly Net Income VS EBIT VS OCF VS FCFCLBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

The Return On Assets of CLBT (-27.36%) is worse than 71.99% of its industry peers.
With a Return On Equity value of -53.44%, CLBT is not doing good in the industry: 68.44% of the companies in the same industry are doing better.
CLBT's Return On Invested Capital of 11.22% is amongst the best of the industry. CLBT outperforms 87.94% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLBT is significantly below the industry average of 12.26%.
The 3 year average ROIC (7.06%) for CLBT is below the current ROIC(11.22%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -27.36%
ROE -53.44%
ROIC 11.22%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
CLBT Yearly ROA, ROE, ROICCLBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

Looking at the Operating Margin, with a value of 14.30%, CLBT belongs to the top of the industry, outperforming 81.56% of the companies in the same industry.
CLBT's Operating Margin has improved in the last couple of years.
CLBT has a better Gross Margin (84.06%) than 92.55% of its industry peers.
CLBT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.3%
PM (TTM) N/A
GM 84.06%
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
CLBT Yearly Profit, Operating, Gross MarginsCLBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLBT is still creating some value.
The number of shares outstanding for CLBT has been increased compared to 1 year ago.
The number of shares outstanding for CLBT has been increased compared to 5 years ago.
There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLBT Yearly Shares OutstandingCLBT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLBT Yearly Total Debt VS Total AssetsCLBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CLBT has an Altman-Z score of 7.30. This indicates that CLBT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CLBT (7.30) is better than 77.31% of its industry peers.
CLBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.3
ROIC/WACC1.17
WACC9.6%
CLBT Yearly LT Debt VS Equity VS FCFCLBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CLBT has a Current Ratio of 1.82. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
CLBT has a Current ratio (1.82) which is comparable to the rest of the industry.
A Quick Ratio of 1.79 indicates that CLBT should not have too much problems paying its short term obligations.
The Quick ratio of CLBT (1.79) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.79
CLBT Yearly Current Assets VS Current LiabilitesCLBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.91% over the past year.
CLBT shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.05%.
Measured over the past years, CLBT shows a quite strong growth in Revenue. The Revenue has been growing by 18.47% on average per year.
EPS 1Y (TTM)27.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%20.06%

3.2 Future

CLBT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.52% yearly.
The Revenue is expected to grow by 15.23% on average over the next years. This is quite good.
EPS Next Y11.44%
EPS Next 2Y10.76%
EPS Next 3Y14.31%
EPS Next 5Y12.52%
Revenue Next Year18.93%
Revenue Next 2Y18.12%
Revenue Next 3Y17.9%
Revenue Next 5Y15.23%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CLBT Yearly Revenue VS EstimatesCLBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
CLBT Yearly EPS VS EstimatesCLBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 34.66 indicates a quite expensive valuation of CLBT.
Based on the Price/Earnings ratio, CLBT is valued a bit cheaper than 67.73% of the companies in the same industry.
When comparing the Price/Earnings ratio of CLBT to the average of the S&P500 Index (27.29), we can say CLBT is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 29.60, the valuation of CLBT can be described as expensive.
Based on the Price/Forward Earnings ratio, CLBT is valued a bit cheaper than the industry average as 65.96% of the companies are valued more expensively.
CLBT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 21.74.
Industry RankSector Rank
PE 34.66
Fwd PE 29.6
CLBT Price Earnings VS Forward Price EarningsCLBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

69.50% of the companies in the same industry are more expensive than CLBT, based on the Enterprise Value to EBITDA ratio.
75.18% of the companies in the same industry are more expensive than CLBT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 27.63
EV/EBITDA 41.48
CLBT Per share dataCLBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CLBT's earnings are expected to grow with 14.31% in the coming years.
PEG (NY)3.03
PEG (5Y)N/A
EPS Next 2Y10.76%
EPS Next 3Y14.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLBT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CELLEBRITE DI LTD

NASDAQ:CLBT (7/7/2025, 8:08:36 PM)

After market: 15.43 +0.18 (+1.18%)

15.25

-0.2 (-1.29%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-13 2025-08-13/bmo
Inst Owners41.93%
Inst Owner Change0%
Ins Owners2.71%
Ins Owner ChangeN/A
Market Cap3.65B
Analysts84.29
Price Target25.5 (67.21%)
Short Float %1.02%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.43%
Min EPS beat(2)0.93%
Max EPS beat(2)15.93%
EPS beat(4)4
Avg EPS beat(4)40.28%
Min EPS beat(4)0.93%
Max EPS beat(4)86.74%
EPS beat(8)8
Avg EPS beat(8)63.98%
EPS beat(12)10
Avg EPS beat(12)43.82%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.92%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)-0.26%
Revenue beat(4)2
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.78%
Revenue beat(8)6
Avg Revenue beat(8)1.51%
Revenue beat(12)7
Avg Revenue beat(12)-0.3%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.54%
PT rev (3m)-10.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.31%
EPS NY rev (1m)0%
EPS NY rev (3m)8.73%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-2.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.9%
Valuation
Industry RankSector Rank
PE 34.66
Fwd PE 29.6
P/S 8.71
P/FCF 27.63
P/OCF 25.54
P/B 10.05
P/tB 11.28
EV/EBITDA 41.48
EPS(TTM)0.44
EY2.89%
EPS(NY)0.52
Fwd EY3.38%
FCF(TTM)0.55
FCFY3.62%
OCF(TTM)0.6
OCFY3.92%
SpS1.75
BVpS1.52
TBVpS1.35
PEG (NY)3.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.36%
ROE -53.44%
ROCE 14.2%
ROIC 11.22%
ROICexc 375.49%
ROICexgc N/A
OM 14.3%
PM (TTM) N/A
GM 84.06%
FCFM 31.53%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.94%
ROCE(5y)9.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 102.56%
Cap/Sales 2.58%
Interest Coverage 250
Cash Conversion 202.89%
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.79
Altman-Z 7.3
F-Score4
WACC9.6%
ROIC/WACC1.17
Cap/Depr(3y)92.67%
Cap/Depr(5y)99.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y11.44%
EPS Next 2Y10.76%
EPS Next 3Y14.31%
EPS Next 5Y12.52%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%20.06%
Revenue Next Year18.93%
Revenue Next 2Y18.12%
Revenue Next 3Y17.9%
Revenue Next 5Y15.23%
EBIT growth 1Y41.52%
EBIT growth 3Y30.51%
EBIT growth 5YN/A
EBIT Next Year30.19%
EBIT Next 3Y22.99%
EBIT Next 5Y18.58%
FCF growth 1Y269.63%
FCF growth 3Y63.25%
FCF growth 5Y65.07%
OCF growth 1Y228%
OCF growth 3Y54.2%
OCF growth 5Y52.3%